Apellis Pharmaceuticals, Inc. (APLS) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Company Overview - Apellis is a commercial biopharmaceutical company focused on the complement biology system, which is part of the innate immune system [2] - The company targets diseases within the complement system, specifically at the central point known as C3 [3] Product Information - Apellis has developed two commercial drugs aimed at addressing diseases related to the complement system [3]